Page 5 - Ted Tenthoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ted tenthoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ted Tenthoff Today - Breaking & Trending Today

ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript

ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
ChemoCentryx Inc (NASDAQ: CCXI)
Operator
Good day and thank you for standing by. Welcome to the ChemoCentryx First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today s conference is being recorded. [Operator Instructions]
I would now like to hand the conference over to Lee Roth of Burns McClellan. Please go ahead, sir.SPONSORED:
10 stocks we like better than ChemoCentryx ....

United States , Vifor Pharma , Thomas Schall , Anupam Rama Jpmorgan , Anupam Rama , Raymond James , Edward Tenthoff Piper Sandler , Glen Massie , Michelle Gilson , Timur Ivannikov Raymond James , Hidradenitis Suppurativa , Steve Seedhouse , Dburns Mcclellan , David Jayne , Susan Kanaya , Yanan Zhu , Red White , Thomasj Schall , Susanm Kanaya , Piper Sandler , Josephp Schwartz , Timur Ivannikov , Hidradenitis Suppurativa Hurley , Ted Tenthoff , Lee Roth , Joe Schwartz ,

Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2020 Earnings Call Transcript

Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX)
Popular Searches
Operator
Good afternoon everyone and welcome to the Eloxx Pharmaceuticals Fourth Quarter and Full Year 2020 earnings webcast and conference call. Today s call is being recorded.
At this time, I would like to turn the call over to Barbara Ryan, Eloxx Investor Relations. Please begin.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see ....

United States , Benjamin Freedman , Edward Tenthoff Piper Sandler , Stepheng Macdonald , Piper Sandler , Greg Williams , Michelle Gilson , Steve Macdonald , Neil Belloff , Ted Tenthoff , Barbara Ryan , Tom Haverty , Matt Goddeeris , Eitan Kerem , Matthew Goddeeris , Steven Mcdonald , University Of Maryland , Eloxx Pharmaceuticals , Cystic Fibrosis Foundation , Michelle Gilson Canaccord Genuity Inc , Eloxx Pharmaceuticals Inc , Hubrecht Organoid Technology , University Of Washington , Clinical Pharmacology In Drug Development , Journal Of Experimental Eye Research , Professor Of The Division Nephrology ,

Gamida Cell Ltd. (GMDA) Q4 2020 Earnings Call Transcript

Gamida Cell Ltd. (GMDA) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Gamida Cell Ltd. (NASDAQ: GMDA)
Q4 2020 Earnings Call
Ladies and gentlemen, thank you for standing by. Welcome to Gamida Cell s conference call for the full-year financial 2020 results. My name is Brandi, and I ll be your operator for today s call. Please be advised that this call is being recorded at Gamida Cell s request.
Now I would like to introduce your host for today s conference, Mr. Josh Hamermesh, chief business officer. Please go ahead.
Josh Hamermesh
Chief Business Officer
Thank you, Brandi, and good morning, everyone. Welcome to today s call, during which we will provide an update on the company and review our financial results for the full year of 2020. Earlier this morning, we issued a press release summarizing our financial results and progress across the company ....

United States , Kiryat Gat , Veronika Bachanova , Roy Buchanan , Ted Tenthoff Piper Sandler , Linda Stamler , Gil Blum , Josh Hamermesh , Jonathan Miller Evercore , Jason Butler , Gregory Renza , Rocio Manghani , Piper Sandler , Jonathan Miller , Mark Breidenbach , Michele Korfin , Tracey Lodie , Ted Tenthoff , Richard Childs , Shai Lankry , Julian Adams , Ronit Simantov , Israeli Innovation Authority , American Society Of Hematology Conference , National Institutes Of Health , Needham Company ,

ChemoCentryx Inc (CCXI) Q4 2020 Earnings Call Transcript

ChemoCentryx Inc (CCXI) Q4 2020 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , Thomas Schall , Raymond James , Ted Tenthoff Piper Sandler , Michelle Gilson , Steve Seedhouse , Dburns Mcclellan , Susan Kanaya , John Frueh , Yanan Zhu , Thomasj Schall , Michelle Gilson Canaccord Genuity , Susanm Kanaya , Piper Sandler , Steve Seedhouse Raymond James , Ted Tenthoff , Lee Roth , European Medicines Agency , Advisory Committee , Chemocentryx Inc , Chemocentryx Fourth Quarter , Full Year , Results Conference , Vice President , Investor Relations , Chief Executive Officer ,

Arrowhead Pharmaceuticals, Inc (ARWR) Q1 2021 Earnings Call Transcript

Operator
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals conference call. [Operator Instructions] I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, sir.
Vincent Anzalone
Vice President, Head of Investor Relations
Thanks, Aldan. Good afternoon, everyone. Thank you for joining us today to discuss Arrowhead s results for its fiscal 2021 first quarter ended December 31, 2020. With us today from management are President and CEO, Dr. Christopher Anzalone; who will provide an overview of the quarter; Dr. James Hamilton, our Senior Vice President of Discovery and Translational Medicine, who has graciously agreed to sub in for Dr. Javier San Martin while he is out ill today; and Ken Myszkowski, our Chief Financial Officer, who will give a review of the financials. In addition, James Hassard, our Chief Commercial Officer, will be available during the Q&A portion of today s call. ....

United States , Piper Sandler , Maury Raycroft , Christopher Anzalone , James Hassard , Ken Myszkowski , Alethia Young , Esther Rajavelu , Ted Tenthoff , Patrick Trucchio , Vince Anzalone , Estherp Rajavelu , James Hamilton , Salveen Richter , Chris Anzalone , American Heart Association , Maurice Thomas Raycroft Jefferies , Salveen Jaswal Richter Goldman Sachs Group Analyst , Investment Bank Analyst , Goldman Sachs , Arrowhead Pharmaceuticals Inc , Head Of Clinical Development , Arrowhead Pharmaceuticals , European Society Of Cardiology , Shawn Michael Egan Citigroup Inc , Securities Exchange ,